About MRWEB_Admin_hqTe42@HD48w@3

This author has not yet filled in any details.
So far MRWEB_Admin_hqTe42@HD48w@3 has created 10 blog entries.

NTRC Therapeutics rebrands itself to Crossfire Oncology

NTRC Therapeutics, a biotech company specialized in the research and development of kinase inhibitors and degraders, will continue under the name Crossfire Oncology.

Founded in 2011 as Netherlands Translational Research Center, NTRC originally pursued a dual business model providing services to

11 September 2023|


Feugiat venenatis placerat consequat metus eu ornare vitae viverra dui volutpat purus augue blandit amet nunc ut lacinia.

24 July 2023|

Senior scientist

Eget ullamcorper neque sem pellentesque condimentum tellus vulputate sed netus erat lacus proin mauris scelerisque quisque aliquam.

24 July 2023|